P. Rae

1.8k citations

8 papers · 1.4k indexed · 1 hit paper · h-index 6

Impact in

Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Genetics top 1%
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Hematology 7
- Chronic Myeloid Leukemia Treatments 5
- Acute Myeloid Leukemia Research 2
Genetics 5
- Chronic Lymphocytic Leukemia Research 5

Co-authors: Francis J. Giles (7 shared papers)Margaret Dugan (6 shared papers)Jörge E. Cortes (6 shared papers)Hagop M. Kantarjian (7 shared papers)Maher Albitar (6 shared papers)Kapil N. Bhalla (3 shared papers)Oliver G. Ottmann (4 shared papers)Leila Alland (5 shared papers)
Journals: Blood (4 papers)Leukemia (1 paper)Clinical Cancer Research (1 paper)Journal of Clinical Oncology (1 paper)New England Journal of Medicine (1 paper)
Partner nations: United States Germany Switzerland

In The Last Decade

P. Rae

8 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL 2006 · 970 citations

Peers

Countries citing papers authored by P. Rae

Since Specialization

Citations

This map shows the geographic impact of P. Rae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Rae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Rae more than expected).

Fields of papers citing papers by P. Rae

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Rae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Rae. The network helps show where P. Rae may publish in the future.

Co-authors

The 25 scholars most cited alongside P. Rae, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. Rae Line = papers co-authored together P. Rae links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work
1	Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL New England Journal of Medicine ·Hagop M. Kantarjian, Francis J. Giles, Lydia Wunderle, Kapil N. Bhalla, Susan O’Brien, Barbara Waßmann, Chiaki Tanaka, Paul W. Manley, P. Rae, William Mietlowski, Kathy Bochinski, Andreas Hochhaus, James D. Griffin, Dieter Hoelzer, Maher Albitar, Margaret Dugan, Jörge E. Cortes, Leila Alland, Oliver G. Ottmann Hit paper breakdown →	2006	970
2	A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients with Refractory Hematologic Malignancies Clinical Cancer Research ·Francis J. Giles, Thomas Fischer, Jörge E. Cortes, Guillermo Garcia‐Manero, Joachim Beck, Farhad Ravandi, Eric Masson, P. Rae, Glen Laird, Sunil Sharma, Hagop M. Kantarjian, Margaret Dugan, Maher Albitar, Kapil N. Bhalla	2006	264
3	UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia Leukemia ·Jonathan B. Singer, Yaping Shou, Francis J. Giles, H Kantarjian, Yanzhi Hsu, Anna Robeva, P. Rae, Aaron Weitzman, Joanne M. Meyer, Margaret Dugan, Oliver G. Ottmann	2007	91
4	A Phase I/II Study of AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, on a Continuous Daily Dosing Schedule in Adult Patients (pts) with Imatinib-Resistant Advanced Phase Chronic Myeloid Leukemia (CML) or Relapsed/Refractory Philadelphia Chromosome (Ph+) Acute Llymphocytic Leukemia (ALL). Blood ·Francis J. Giles, Hagop M. Kantarjian, Barbara Waßmann, Jörge E. Cortes, Susan O’Brien, C. Tanaka, P. Rae, William Mietlowski, Andrea Romano, Leila Alland, Margaret Dugan, Maher Albitar, Oliver G. Ottmann	2004	26
5	AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has Significant Activity in Imatinib-Resistant Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome Positive Acute Lymphoid Leukemia (Ph + ALL). Blood ·Hagop M. Kantarjian, O. Ottman, Jörge E. Cortes, M. Wassman, Lydia Wunderle, Kapil N. Bhalla, Dan Jones, Andreas Hochhaus, P. Rae, Leila Alland, Michael J. Dugan, Maher Albitar, Francis J. Giles	2005	17
6	Activity of AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, in imatinib-resistant bcr-abl positive lymphoid malignancies Journal of Clinical Oncology ·Oliver G. Ottmann, Frank Giles, Barbara Waßmann, Andreas Hochhaus, P. Rae, M Beran, Maher Albitar, Leila Alland, Michael J. Dugan, Hagop M. Kantarjian	2005	7
7	A Phase I/II Study of Intravenous LBH589, a Novel Histone Deacetylase (HDAC) Inhibitor, in Patients (pts) with Advanced Hematologic Malignancies. Blood ·Francis J. Giles, Thomas Fischer, Jörge E. Cortes, James D. Beck, Farhad Ravandi‐Kashani, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Bin Peng, P. Rae, Glen Laird, Samil Sharma, Margaret Dugan, Maher Albitar, Kapil M. Bhalla	2004	5
8	AMN107, Novel Aminopyrimidine Inhibitor of Bcr-Abl, Is Significantly More Potent Than Imatinib Mesylate Against Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Cells. Blood ·Mirna Golemović, Miloslav Beran, Francis J. Giles, Taghi Manshouri, Deborah A. Thomas, Jörge E. Cortes, Paul W. Manley, Leila Alland, P. Rae, Margaret Dugan, Zeev Estrov, Ralph B. Arlinghaus, Hagop M. Kantarjian, Srđan Verstovšek	2004	1

About P. Rae

P. Rae is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Molecular Biology and Rheumatology, having authored 8 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Histone Deacetylase Inhibitors Research (2 papers), Acute Myeloid Leukemia Research (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Epigenetics and DNA Methylation (1 paper) and Gestational Trophoblastic Disease Studies (1 paper). The work is most often cited by research in Hematology (984 citations), Genetics (679 citations), Rheumatology (476 citations), Oncology (279 citations) and Molecular Biology (412 citations). P. Rae has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Francis J. Giles, Margaret Dugan, Jörge E. Cortes, Hagop M. Kantarjian, Maher Albitar, Kapil N. Bhalla, Oliver G. Ottmann, Leila Alland, Barbara Waßmann and William Mietlowski. Their work appears in journals such as Blood, Leukemia, Clinical Cancer Research, Journal of Clinical Oncology and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact